Boston Scientific Corporation June 15th Short Interest Update

Boston Scientific Corporation (NYSE:BSX), A increase of 923,977 shares or 4.1% was observed in the short interest of Boston Scientific The interest on June 15,2016 came in at 23,595,642 shares and as per the average daily trading of 10,865,512 shares, the days to cover are 2. The increased interest is 1.8% of the floated shares. The data of May 31,2016 put the interest at 22,671,665 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

Boston Scientific Corporation (NYSE:BSX): The stock opened at $22.35 on Friday but the bulls could not build on the opening and the stock topped out at $22.95 for the day. The stock traded down to $22.30 during the day, due to lack of any buying support eventually closed down at $22.37 with a loss of -2.61% for the day. The stock had closed at $22.97 on the previous day. The total traded volume was 39,356,606 shares.

The company shares have rallied 25.60% from its 1 Year high price. On Jun 9, 2016, the shares registered one year high at $23.35 and the one year low was seen on Aug 24, 2015. The 50-Day Moving Average price is $22.58 and the 200 Day Moving Average price is recorded at $19.42.

Boston Scientific Corporation (NYSE:BSX) has tumbled 0.53% during the past week and has dropped 0.93% in the last 4 week period. In the past week, the company has outperformed the S&P 500 by 1.12% and the outperformance has advanced to 2.07% for the last 4 weeks period.

Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.